DIN 02368153 — XGEVA 120 MG
XGEVA is a solution of Denosumab marketed by AMGEN CANADA INC. The full Denosumab monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02368153
- Brand name
- XGEVA
- Active ingredient
- Denosumab
- Strength
- 120 MG
- Dosage form
- SOLUTION
- Route
- SUBCUTANEOUS
- Manufacturer
- AMGEN CANADA INC
- Health Canada status
- MARKETED
- Drug class
- RANK ligand (RANKL) inhibitor (bone metabolism regulator)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Denosumab products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02565951 | BILDYOS | 60 MG | SOLUTION | SHANGHAI HENLIUS BIOTECH, INC. | MARKETED |
| 02566265 | DENOZA | 60 MG | SOLUTION | APOTEX INC | MARKETED |
| 02545411 | JUBBONTI | 60 MG | SOLUTION | SANDOZ CANADA INCORPORATED | MARKETED |
| 02560895 | OSENVELT | 120 MG | SOLUTION | CELLTRION INC. | MARKETED |
| 02343541 | PROLIA | 60 MG | SOLUTION | AMGEN CANADA INC | MARKETED |
| 02560917 | STOBOCLO | 60 MG | SOLUTION | CELLTRION INC. | MARKETED |
| 02566001 | TUZEMTY | 120 MG | SOLUTION | SHANGHAI HENLIUS BIOTECH, INC. | MARKETED |
| 02545764 | WYOST | 120 MG | SOLUTION | SANDOZ CANADA INCORPORATED | MARKETED |